August 2005 – The CenterWatch Monthly : PDF
Singapore: Hub for Clinical Trials in Asia
The clinical trials market in Singapore has doubled in size since the country adopted ICH-GCP in 1998. Bolstered by well-developed technology and hospital infrastructures, strict adherence to international standards, considerable investment by multinational pharmaceutical, biotech companies and CROs, and a well-educated English-speaking population, Singapore has become an attractive place to conduct clinical trials.
Analysis: US Newspapers Fail to Report on Trial Risks, Benefits
CenterWatch has recently completed a survey of how the top daily newspapers in the United States report on clinical trials and found that their reporting for the most part failed to discuss potential risks and benefits for patients.
Education, Customization Key to BBK Recruitment in EU
Patient recruitment is still in its infancy in most European countries, and BBK Healthcare of Newton, Mass. has been at the forefront of efforts in the EU.
Eye on: Sexually Transmitted Diseases
About 1.4 million adults in the U.S. have sexually transmitted diseases. CenterWatch has identified a pipeline of 39 drugs in development for sexually transmitted diseases.